Palantir Faces Insider Sales, Swiss Scrutiny, and Compliance Push Amid High Valuations
Palantir’s insider sales, Swiss regulatory scrutiny and new compliance partnership raise high‑valuation risks – investors should track earnings, EU filings and Oligo deals for signals of sustainable cash‑flow growth.
5 minutes to read






